Tech Company Financing Transactions
EnteroBiotix Funding Round
EnteroBiotix secured a $34.1 million funding round on 4/4/2024. Backers included Kineticos Ventures, Scottish Enterprise and Scottish Investment Bank.
Transaction Overview
Company Name
Announced On
4/4/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$34,120,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to advance its lead product candidate, EBX-102-02 through a Phase 2 clinical trial in Irritable Bowel Syndrome in partnership with the Functional Gut Clinic, as well as to progress its pipeline for other conditions linked to a disrupted gut microbiome, including liver cirrhosis and hepatic encephalopathy ('HE').
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Aberdeen Blood Donor Centre Foresterhill Health Campus Fores
Scotland, AB25 2ZW
UK
Scotland, AB25 2ZW
UK
Phone
Website
Email Address
Overview
Our mission is to transform the lives of patients through best-in-class microbiome medicines. Ambitious for patients: We put the needs of patients first in everything we do. We stay focussed on delivering what matters most, faster and better.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Elmar Schnee
Chief Executive Officer
James McIlroy
Chief Financial Officer
Chris Lea
Chief Operating Officer
James Barnes
VP - Human Resources
Kimberley McAleney
Browse more venture capital transactions:
Prev: 4/4/2024: Ironic Biotech venture capital transaction
Next: 4/4/2024: Telness Tech venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs